MedPath
NMPA Approval

Doxofylline Injection

国药准字H20244561

July 30, 2024

Drug Information

多索茶碱注射液

注射剂

10ml:0.1g

化学药品

July 30, 2024

Company Information

Applicant Company

陕西省西安市高新区新型工业园创新路7号

Manufacturing Company

陕西省西安市高新区新型工业园创新路7号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多索茶碱注射液 - NMPA 批准文号 | MedPath